Chidimatsu Hikari, Matsui Hiroto, Tokumitsu Yukio, Matsukuma Satoshi, Shindo Yoshitaro, Tomochika Shinobu, Yoshida Shin, Iida Michihisa, Suzuki Nobuaki, Takeda Shigeru, Hasegawa Hiroyasu, Yoshino Shigefumi, Hazama Shoichi, Ueno Tomio, Nagano Hiroaki
Dept. of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine.
Gan To Kagaku Ryoho. 2019 Dec;46(13):2425-2427.
The patient was a 66-year-old man presenting with epigastric pain and jaundice. PET-CT demonstrated limited-accumulation on the tumor at the head of the pancreas, diagnosed as borderline resectable adenosquamous carcinoma. The patient was treated with preoperative chemoradiation therapy with 2 courses of gemcitabine followed by administration of S-1 and gemcitabine for 13 months, which reduced the tumor size. After preoperative therapy, pancreaticoduodenectomy was performed. Histopathological examination revealed that no viable tumor cells were detected in the pancreas or lymph nodes, and the patient had achieved a pathological complete response. Postoperative adjuvant chemotherapy was not performed, and the patient is still alive without recurrence for 66 months after surgery.
该患者为一名66岁男性,表现为上腹部疼痛和黄疸。正电子发射断层扫描-计算机断层扫描(PET-CT)显示胰腺头部肿瘤有局限性积聚,诊断为可切除边缘的腺鳞癌。患者接受了术前放化疗,先用2个疗程的吉西他滨,随后给予S-1和吉西他滨治疗13个月,肿瘤大小缩小。术前治疗后,进行了胰十二指肠切除术。组织病理学检查显示,胰腺或淋巴结中未检测到存活的肿瘤细胞,患者达到了病理完全缓解。未进行术后辅助化疗,患者术后66个月仍存活且无复发。